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Serum response factor (SRF) gene expression in avian embryonic muscle lineages plays a central role in activating a-actin
gene activity. In early stage HH 6 avian embryos, SRF mRNA expression showed strong localization to the neural groove,
primitive streak, lateral plate mesoderm, and Hensen's node, while distinct SRF expression was seen later in the neural
folds and the somites by HH stage 8. SRF transcripts appeared in the precardiac splanchnic mesoderm in stage HH 9
embryos and was detected at higher levels in the myocardium, somites, and lateral mesoderm of HH 11 embryos. SRF
antibody staining demonstrated signi®cant SRF protein accumulation in the myocardium of the developing heart and the
myotomal portion of somites. During primary myogenesis in culture, SRF transcripts and nuclear SRF protein content
increased about 40-fold, as primary myoblasts withdrew from the cell cycle, reaching their highest levels prior to the
upregulation of the skeletal a-actin gene. A dominant-negative SRF mutant, SRFpm1, which inhibited DNA binding, but
not dimerization of monomeric SRF subunits, blocked transcriptional activation of a skeletal a-actin promoter±luciferase
reporter gene during myogenesis. Transcriptional blockade was reversed by co-transfections of a wild-type SRF expression
vector, but was not rescued by the expression of other myogenic factors, such as MyoD and Mef-2C. Thus, SRF displayed
an embryonic expression pattern restricted primarily to striated muscle cell lineages, in which increased mass of nuclear
SRF was obligatory for a-actin gene transcription. q 1996 Academic Press, Inc.
INTRODUCTION Hardeman, 1993; Coleman et al., 1995). Mutagenesis stud-
ies of skeletal a-actin promoters has demonstrated that
CBAR/CArG boxes played a positive role in myogenic in-Expression of a-actin genes during early avian (Ruzicka
duction (Bergsma et al., 1986; Muscat and Kedes, 1987;and Schwartz, 1988) and mammalian embryogenesis (Sas-
Grichnik et al., 1988; Chow and Schwartz, 1990). CArGsoon et al., 1989; Sawtell and Lessard, 1989) are among the
boxes were also critical to the muscle-speci®c inductionearliest markers for cells committed to cardiac, skeletal, and
of the chicken (Quitschke et al., 1989; Moss et al., 1994),smooth muscle cell lineages. Gene transfer and transgenic
Xenopus (Mohun et al., 1989), and human (Miwa and Kedes,experiments (Petropoulos et al., 1989) have indicated that
1987) cardiac a-actin promoters. In addition to the multiplethe capacity for selective genetic expression of the sarco-
CArG boxes, the human cardiac a-actin promoter requiredmeric a-actin genes resides mainly within the 5* promoter
the combination of an intact MyoD-binding E box and Sp1and immediate DNA ¯anking sequences, but can be
site for activity in myogenic cells (Sartorelli et al., 1990).strongly in¯uenced by upstream enhancers (Biben et al.,
Likewise, the avian cardiac a-actin promoter was regulated1994) and 3* noncoding regions of these genes (Brennan and
through a pair of complex elements composed of E boxes
and CArG boxes (French et al., 1989; Moss et al., 1994).
Originally recognized as an essential core element of the1 To whom correspondence should be addressed at Department
c-fos promoter, the serum response element (SRE) was ®rstof Cell Biology, One Baylor Plaza, Houston, TX 77030. Fax: (713)
798-7799. associated with serum responsiveness and the rapid expres-
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sion of several immediate early genes (Treisman 1985, 1986, muscle, and to a lesser extent to cell types of neuroectoder-
mal origins (Yu et al., 1992). Like MEF-2, SRF was virtually1987; Gilman et al., 1986). The highly conserved SRE motif,
CC(A/T)6GG, is equivalent to the CBAR (Bergsma et al., absent in endodermal-derived tissues, and SRF protein ap-
peared exclusively during early embryonic heart and skele-1986) and CArG box (Minty and Kedes, 1986) motifs, found
as multiple copies within the 5* ¯anking regions of all se- tal muscle formation. Similarly, avian SRF mRNA and pro-
tein were observed to be dramatically increased, as primaryquenced vertebrate a-actin genes. Analysis of DNA±protein
interactions of this sequence resulted in the identi®cation myoblasts withdrew from the cell cycle and fused, with
expression reaching maximal levels in differentiated myo-and cloning of serum response factor (SRF) which bound as
a dimer and symmetrically contacted various SREs. Cloning tubes. Thus, induction of SRF transcripts appeared prior to
the upregulation of thea-actin gene activity during myogen-of human (Norman et al., 1988) and Xenopus (Mohun et
al., 1991) SRF cDNAs helped to de®ne the DNA-binding/ esis (Hayward and Schwartz, 1986; Hayward et al., 1988).
To investigate if SRF had a primary role in activating thedimerization domain of SRF, termed the MADS box, which
shared striking functional homology to yeast transcription skeletal a-actin promoter, a dominant-negative SRF mu-
tant, SRFpm1, which inhibited endogenous SRF DNA-bind-factors MCM1 and Arg 80 (Mueller and Nordheim, 1991).
The amino-terminal basic extension region of the MADS ing activity was observed to block transcriptional activity
of SRE containing promoters and the activation of skeletalbox was part of the DNA-binding domain, while an immedi-
ately adjacent region directed subunit dimerization and re- a-actin gene in differentiating myogenic cultures. Our stud-
ies demonstrated an SRF gene expression pattern restrictedcruitment of accessory factors. Recent studies suggest that
MADS box proteins, MCM1, and SRF link genes to signal primarily to striated and smooth muscle cell lineages, in
which increased mass of nuclear SRF appeared to be re-transduction pathways (Treisman and Ammerer, 1992). In
addition, both MCM1 and SRF are known to interact with quired for a-actin gene transcription.
homeodomain proteins (Keleher et al., 1988; Grueneberg et
al., 1992; Vershon and Johnson, 1993) that can achieve tis-
sue- and cell-type-speci®c gene expression. MATERIALS AND METHODS
We observed that SRF binding activity was increased dur-
ing myogenesis in primary cultured myoblasts, which corre- Isolation of avian serum response factor cDNA. Avian SRF
cDNA was isolated from a Lambda ZAP chicken Embryonic Daylated well with the appearance of the a-actins. Some SREs
17 skeletal muscle cDNA library using the complete coding regiondisplayed myogenic regulatory properties (Lee et al., 1992).
of the human SRF cDNA as a homologous probe. Six clones wereThe activity of the proximal avian skeletal a-actin SRE was
isolated which represented 2300 bp of overlapping sequence. Theupregulated during myogenesis when af®xed on a minimal
primary sequence of this avian SRF was determined by dideoxypromoter (Walsh, 1989). SRF was shown to be a positive
sequencing of Sanger et al. (1977) and deposited in GenBankacting factor for driving a-actin promoter activity, by com-
(U50596). The deduced amino acid sequence was highly homolo-
peting against a negative acting YY1 factor for binding on gous with the amino acid sequences of human (Norman et al.,
the proximal SRE (Lee et al., 1992; Gualberto et al., 1992). 1988) and Xenopus (Chambers et al., 1992) SRF and absolutely
In addition, Vandromme et al. (1992) elegantly showed that conserved within the MADS box 90 amino acid region. The 3*
microinjection of SRF antibodies prevented the myoblast± untranslated region was approximately 1130 nucleotides in length
containing two consensus poly(A)/ addition sequences. The avianmyotube progression, the expression of the myogenic factor
SRF mRNA probe used as a probe for the RNA-Northern blots wasmyogenin, and the appearance of troponin T, thereby im-
constructed from an 1100-bp SmaI fragment released from an avianplying an early requirement for SRF in myogenic differentia-
SRF which encompassed the ®nal 238 amino acids of the C terminaltion. However, in comparison to the myogenic-restricted
region of SRF and ends 260 bp from the stop codon in the 3* UTR.expression of MyoD bHLH factors (see review Olson, 1992),
The resulting fragment did not contain any portion of the MADSit still has been dif®cult to reconcile a myogenic regulatory
box DNA-binding/dimerization domain of SRF.
role for SRF when it is generally assumed to be a ubiquitous Plasmid constructs. A cytomegalovirus promoter driven ex-
transcription factor, cloned from Hela cells (Norman et al., pression vector, pCGN, was used to construct the following plas-
1988). The impetus to determine more exactly the mecha- mid vectors: a wild-type human SRF, pSRF, a carboxy-terminal
nisms involved in SRF control over the skeletala-actin gene deletion of the SRF activation domain, pSRF 1-338 (Lee et al., 1992),
and a triple point mutant SRFpm1 which converted Arg143, Lys145,was strengthened by the discovery of the SRF-related pro-
and Leu146 to Ile143, Ala145, and Gly146 (Johansen and Prywes, 1993).teins (RSRF or MEF-2) capable of binding MEF-2 sites,
The avian skeletal a-actin promoter construct from 0424 to /24CTA(A/T)4TAG, which can be found in the regulatory re-
bp described previously (Chow and Schwartz, 1990) was linked togions of both nonmuscle and muscle-speci®c genes (Pollack
the ®re¯y luciferase reporter gene (MacLellan et al., 1994).and Treisman, 1991; see review Olson et al., 1995).
SRF DNA-binding assays. The bacterial expression vectorHow does SRF ®t into a central role for regulating a-
pAR3040 was used to express SRF wild-type, SRF1-508 , deletion mu-striated actin genes and how might SRF contribute to tissue tant, SRF1-244 , and dominant-negative mutant SRFpm1 proteins in
restricted expression? Here we showed that avian SRF gene log growing Escherichia coli BL21. After the addition of IPTG to
activity was reminiscent of the expression pattern of MEF- induce Lac promoter activity, transformed bacteria were resus-
2, being primarily restricted to cell types derived from em- pended in BC100 (10 mM Tris, pH 7.9, 100 mM KCl, 20% glycerol)
and lysed by sonication. The bacterial extracts were cleared by 10bryonic mesoderm such as skeletal, cardiac, and smooth
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min centrifugation at 13,000 rpm. The proteins were denatured by acetone at 0207C for 90 sec. The coverslips were washed three
times in 11 PBS. The coverslips were placed cells side down onto 50mixing with 4 vol of 6 M guanidine HCl in BC100 and renatured
by mixing with 1 vol of BC100 followed by dialysis against BC100. ml of primary anti-SRF (Manak and Prywes, 1993) antibody (1:1000
dilution) for 45 min at 377C. The cells were washed in 11 PBSDialyzed proteins were used in electrophoretic mobility shift
three times and placed on top of 50 ml of secondary antibody (1:200assays (EMSA). Samples were incubated for 30 min with gel shift
dilution goat anti-rabbit ¯uorescein-conjugated antibody from Cap-buffer (5% glycerol, 50 mM KCl, 1 mM DTT, 1 mM EDTA, 2 mM
pel). The cells were washed with 11 PBS and mounted onto slidesspermidine, and 0.1 mg/ml herring sperm DNA) and then run at
with PBS:glycerol (1:9). Staining was visualized under ¯uorescence150 V on 4% PAGE using 0.251 TBE as running buffer. Whole
optics with a Zeiss Axiophot microscope.cell extracts and gel shifts from primary myoblast cultures were
RNA hybridization assays. Total RNA was obtained from pri-performed as described previously (Lee et al., 1991). All EMSAs
mary myoblast cultures and tissues according to Chomczynski andused the duplexed, 32P-labeled SRE1 oligonucleotide from the skele-
Sacchi (1987). Total RNA (20 mg) was electrophoresed on a 1%tal a-actin promoter as a probe (Lee et al., 1991).
formaldehyde agarose slab gel and transferred onto MSI mem-In situ hybridization and immunohistochemistry. Fertilized
branes. The chicken avian SRF (1100-bp SmaI fragment), MyoDWhite Leghorn eggs were obtained from the Department of Poultry
(1100-bp PstI/EcoRI fragment), and the skeletal a-actin 3* UTRScience (Texas A & M University) and incubated at 377C. Embryos
(Hayward and Schwartz, 1986) cDNA probes were labeled by ran-were collected and staged according to Hamburger and Hamilton
dom priming using [a-P32]dCTP and hybridized at 687C in 51 SSC,(1951). Sectioning and in situ hybridizations were performed as
51 Denhardt's, and 1% SDS for 16 hr. Blots were washed at 687Cdescribed by Sundin et al. (1990). Whole mount hybridizations were
under high-stringency conditions, 0.11 SSC and 0.1% SDS. To de-performed as described in Li et al. (1994) with the following excep-
termine distribution of SRF transcripts in late stage chicken embry-tions. Proteinase K digestions were performed at 10 mg/ml for 10
onic tissues, poly(A)/ RNA was collected (Clontech) from Day 18min, hybridizations and washes were performed at 627C, and no
embryos (5 mg/lane) and probed as described above.RNase digestions were performed. A short avian SRF probe (300
Antibodies. Polyclonal antibodies used for immunohistochem-bp), corresponding to a portion of its 3* UTR, was subcloned into
istry, immuno¯uorescence, and Western analysis in Fig. 4G werepBluescript and linearized to produce antisense 35S- and digoxy-
directed against bacterially expressed human SRF (Manak andgenin-labeled riboprobes. All immunostainings were performed
Prywes, 1993). SRF epitope-speci®c antibodies were produced bywith an anti-SRF antibody described in Manak and Prywes (1993)
immunizing rabbits with a polypeptide speci®c to the carboxylat a 1:2000 antibody dilution. Immunoperoxidase staining of avian
region of SRF (NH2-GGHMMYPSPHAVMYA-COOH). This epi-stages 8, 10, and 12 (Figs. 4A±4C) were performed as described in
tope corresponded to amino acid positions 405 to 418 of the humanSundin and Eichele (1990). Immuno¯uorescent immunohisto-
SRF sequence. The epitope was synthesized on Fmoc Multiple An-chemistry of stage 15 embryo sections (Figs. 4D and 4E) was per-
tigenic Peptide Resins which served as an immunological adjuvant.formed using an antibody dilution of 1:500 as described in Parlow
Collected serum was af®nity puri®ed against the epitope as de-et al. (1991).
scribed in Skinner et al. (1987). The epitope-speci®c SRF antibodyPrimary chicken myoblast cultures. Primary embryonic myo-
was used in tissue and myogenic culture extracts.blast cultures were established as described previously (Lee et al.,
SRF Western analysis. Dissected tissues and myogenic cul-1992). Cells were seeded at a density of 2 1 105 cells per 60-mm
tures were rinsed with 11 PBS and homogenized in extractiondish in MEM plus gentamycin with 10% horse serum and 5% chick
buffer [0.5 M Tris±HCl (pH 7.0), 8 M urea, 1% SDS, 0.01% PMSF,embryo extract (CEE) in 5% CO2 at 377C. BudR (5* bromodeoxyuri- 1% b-mercaptoethanol]. The extracts were passed through a 21-dine) was added at 30 mM to repress myogenesis. BudR was with-
gauge needle and cleared for 10 min at 10,000 rpm at 257C. Celldrawn when myoblasts were grown to approximately 70% con¯u-
extracts (10 mg/lane) were fractionated on 10% PAGE±SDS slabence to induce myogenic differentiation. Cells were washed twice
gels, transferred onto Immobilon membrane, and probed with af-with 11 PBS and then incubated with MEM plus gentamycin con-
®nity-puri®ed, epitope-speci®c SRF antibody at a 1:1000 dilution.taining 10% horse serum (HS) and 2% CEE. Cellular samples were
Cross-reacting peptides were detected with anti-rabbit IgG alkalinecollected every 24 hr following BudR withdrawal for RNA and
phosphatase conjugate antibody (1:7500) and developed with ni-protein analysis.
troblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate.
DNA transfection and reporter gene assays. At 48 hr after plat-
The Western blot shown in Fig. 4 was prepared by separating 50
ing, primary cultures were transfected with approximately 1.0 mg
mg total protein from hearts that were isolated at the incubated
of total plasmid DNA containing the skeletal a-actin promoter±
stages of development on a 7.5% acrylamide/SDS gel. Following
luciferase vector (500 ng), various SRF expression vectors (100 ng),
electroblotting to nitrocellulose, the blot was stained with India
and pUC18 (400 ng), which served as a carrier, per 60-mm-diameter
ink (Fig. 4F) and reacted with a 1:2000 dilution of SRF antibody
dish. Plasmid DNA was incubated with 4 ml of lipofectamine for (Manak and Prywes, 1993). Sites of antibody binding were visual-
15 min and plated with 1 ml of DMEM for 4 hr. Afterward, cells ized using ECL (Amersham) according to the manufacturer's proto-
were placed in MEM plus gentamycin with 10% HS and 2% CEE col (Fig. 4G).
without BudR. Cell extracts were collected and luciferase activity
was determined as described in MacLellan et al. (1994). Transfec-
tion experiments were performed in triplicate with two indepen-
RESULTSdently isolated sets, and the results were averaged.
Immuno¯uorescence of myogenic cultures. Primary myoblasts
were plated on collagenized glass coverslips in 35-mm dishes at 5 SRF Expression Restricted to Tissues of
1 104 cells per plate and cultured as described above. At speci®c Mesodermal and Neuroectodermal Origins
timepoints following BudR withdrawal, coverslips were washed in
SRF gene expression was evaluated during avian em-11 PBS (phosphate-buffered saline) and adherent cells were ®xed
in cold methanol for 5 min. The coverslips were placed in cold bryogenesis to determine if SRF gene activity followed a
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FIG. 1. Avian SRF expression at the mRNA, protein, and DNA-binding activity levels was mainly restricted to striated and smooth
muscle embryonic tissues. SRF mRNA, protein, and DNA-binding levels were analyzed in tissues isolated from Day 18 chick embryos.
(A) RNA blot of poly(A)/ RNA (5 mg/lane) isolated from brain, gizzard, heart, leg muscle, and liver tissues was probed with an 1100-bp
cDNA probe corresponding to the C terminal/3 *UTR portion of SRF mRNA and with EF1a to standardize RNA loadings. (B) Whole cell
protein extracts (10 mg/lane) taken from these tissues were probed by Western blotting with an SRF antibody speci®c to a epitope speci®c
to the carboxyl region of SRF (NH2-GGHMMYPSPHAVMYA-COOH). SRF was detected with a Mr of 49 1 103. (C) SRF DNA-binding
activity was tested with whole cell extracts (15 mg) of these tissues by EMSA using the SRE1 of the skeletal a-actin promoter as a probe.
tissue-restricted pattern of expression. The coding region continued to increase in the myocardium through stage 12
embryos prior to its expression in the somites (Ruzicka anddownstream of the MADS box served as a speci®c avian
SRF hybridization probe for Northern blot analysis. Two Schwartz, 1988). We wanted to determine if SRF mRNA
and protein expression patterns were also locally restrictedmRNA species that corresponded to 3.5- and 2.5-kb SRF
mRNA (Fig. 1A) were detected from RNA extracted from to early embryonic cardiac and skeletal muscle cell lineages.
SRF mRNA expression was detected as early as stage 4Day 18 embryonic tissues. These multiple SRF mRNAs
were due to differential 3* polyadenylation (data not shown), throughout the epiblast and in the blood islands, which are
mesodermal cells giving rise to the hematopoetic lineagesas shown for human SRF mRNA (Norman et al., 1988).
SRF mRNA was enriched in cardiac, skeletal, and enteric involved in erythropoeisis and angiogenesis (Fig. 2A). Such
early presence of SRF mRNA was suggestive of a maternallysmooth muscle tissues and to a lesser extent in neuroecto-
derm-derived brain tissue (Fig. 1A). SRF transcripts were stored transcript. In a stage 6 embryo, SRF was widely ex-
pressed with strong localization to the neural groove, thevirtually undetectable in endodermal-derived liver tissue.
Similarly, Western protein blot analysis revealed a higher primitive streak, the lateral plate mesoderm, and the under-
lying endoderm (Fig. 3A). Figures 2B and 2C showed trans-level of SRF protein in leg muscle, gizzard, and cardiac tis-
sue extracts than in brain (Fig. 1B), while SRF protein was verse sections through the region anterior to Hensen's node
(see Fig. 3A for plane of sectioning) and illustrate strongbarely detected in liver tissue. SRF DNA-binding activity,
evaluated by EMSA with a labeled skeletal a-actin proximal SRF expression in the neural plate and lower expression
in the underlying mesendoderm (Fig. 2C). More posteriorSRE1 double-stranded oligonucleotide probe, also displayed
the highest binding activity in extracts collected from car- transverse sections revealed SRF transcripts concentrated
diac and skeletal muscle tissues, lower binding activity in in the primitive streak (Fig. 2D). In the posterior most do-
brain extracts, and no binding activity in liver extracts (Fig. main of the embryo, SRF expression was low and apparently
1C). Thus, SRF gene expression pattern during late stage uniform (Fig. 2E). As can be seen in Fig. 3A, there was an
avian embryogenesis was restricted to striated and smooth enrichment of SRF mRNA on the right side of Hensen's
muscle tissues and to a lesser extent to tissues of neuroec- node, a region which also expressed activin receptor IIa
todermal origins. (Stern et al., 1995). At stage 8, distinct expression was seen
in the neural folds representing the prospective hind-,
mid-, and posterior half of the forebrain (Fig. 3B). At this
Developmental Expression of SRF stage, the somites also expressed the SRF gene. Regions
posterior to the somites (not shown) expressed SRF in aDuring avian embryogenesis, expression of sarcomeric a-
pattern seen in earlier stages (Fig. 3A). By stage 11, SRF wasactin transcripts served as an early marker for differentia-
seen in the neuroectoderm of the brain and the neural tubetion of cardiac and skeletal muscle cell lineages. Cardiac a-
(Figs. 2F±2J and 3D) and in the developing heart (Fig. 3C).actin mRNA was ®rst detected in HH stage 9 embryos in the
Transverse sections revealed high levels of SRF expressionthickened splanchnic mesoderm which forms the proximal
wall of the amniocardiac vesicle. Cardiaca-actin expression in the myocardium and the pharyngeal foregut endoderm
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FIG. 2. Serial transverse sections through chick embryos hybridized to a SRE antisense riboprobe. (A) Stage 4 embryo showed strong
expression in the epiblast and the blood islands. (B±E) Stage 6 embryo revealed expression in the neural groove and neural plate and the
primitive streak. (F±J) Stage 11 embryo; SRF mRNA was abundant in the neural tube, splanchnic mesoderm, somites, and in presomitic
mesoderm. Note the absence of transcripts in the surface ectoderm. All sections were hybridized with a complementary 900-bp riboprobe
that corresponded to the carboxy terminus of avian SRF. The following embryonic tissues are marked as bi, blood islands; ep, epiblast;
lm, lateral plate mesoderm; ng, neural groove; my, myocardium; nt, neural tube; pe, pharyngeal endoderm; ps, primitive streak; s, somites;
sp, splanchnic mesoderm.
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FIG. 3. Whole mount in situ hybridization with SRF antisense riboprobe. (A) Stage 6 embryo. Horizontal lines indicate approximate
level of sectioning shown in Figs. 2B±2E. (B) Stage 8 with 4 somites. Note strong expression in the brain primordium and the newly
formed somites. (C) Ventral view of an early stage 11 embryo emphasizing cardiac expression. (D) Dorsal view of stage 11 embryo.
Horizontal lines indicate approximate level of sectioning shown in Figs. 2F±2J. (E) Enlargement of the region indicated by arrows in (D).
Note the rostrocaudal gradient in SRF expression in the somites shown. The most recently formed somites exhibit lowest levels of SRF
transcript. (F ) Stage 12 embryo hybridized with an SRF sense riboprobe. The following embryonic tissues are marked as hn, Henson's
node; lm, lateral plate mesoderm; ng, neural groove; my, myocardium; ps, primative streak; s, somites.
FIG. 4. SRF protein was localized primarily to the developing myocardium and myotome during avian embryogenesis. (A±D) Transverse
sections of HH stage 8 (A), HH stage 10 (B), HH stage 12 (C), and HH stage 15 (D) avian embryos were probed with an rabbit SRF antibody
produced against bacterially expressed human SRF to detect SRF localization during myocardial development. SRF protein was localized
in the fusing paired primordia of the developing heart (A) and throughout the myocardium in later developmental stages (B±D). (E) Higher
magni®cation of the stage 15 embryo (D) shows SRF localization to the myotome in the somites. The following embryonic tissues are
marked n, neural tube; pp, paired primordia; pe, pharyngeal endoderm; my, myocardium; s, somites. Bar, 66 mm. (F) India ink staining of
electroblotted proteins from isolated hearts. (G) Western analysis showing the upregulation SRF during cardiogenesis. Isolated hearts from
chick embryos collected at various stages of development were probed with the same antibody used in immunostains. SRF was detected
with a Mr of 49 1 103. Note. (A±C) immunoperoxidase; (D, F) immuno¯uorescence; (E) ECL detection.
(Fig. 2F), coincident with cardiac a-actin expression (Ruz- riorly in the somites and the lateral plate mesoderm (Figs.
2G±2J and 3E). Both, transverse sections (Figs. 2I and 2J)icka and Schwartz, 1988). SRF was also detected at high
levels in the splanchnic mesoderm (Fig. 2G) and more poste- as well as whole mounts (Fig. 3E) illustrated a signi®cant
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difference in the level of SRF transcripts in somites and
presomitic mesoderm. Note the absence of SRF expression
in dorsal surface ectoderm and also the lack of speci®c hy-
bridization in a stage 12 embryo hybridized with an SRF
sense riboprobe shown in Fig. 3F.
In contrast to SRF transcripts, the SRF protein appeared
predominantly during cardiac morphogenesis in the avian
embryo. Immunoperoxidase staining was performed with
an antibody directed against bacterially expressed human
SRF. SRF protein was abundant in the fusing paired primor-
dia (Fig. 4A) and myocardium (Figs. 4B±4D) of the devel-
oping heart. The HH stage 15 section (Fig. 4D), which tran-
sected a pair of somites, also showed SRF protein localized
to the somites. Lower levels of SRF was also detected in
the pharyngeal foregut (Fig. 4D). Higher magni®cation of
the somites in Fig. 4D showed SRF protein localized to the
myotomal portion of the anterior somites (Fig. 4E). Interest-
ingly, while SRF mRNA was abundant throughout the neu-
ral tube (Fig. 2), SRF protein was detected only at relatively
low levels in the neural tube at early embryonic stages,
suggesting that translational regulation of SRF mRNA may
further restrict SRF expression activity during early embry-
FIG. 5. Upregulation of SRF mRNA transcripts during myogen-
onic development. Western analysis of protein isolated from esis of avian primary myoblast cultures. RNA collected at time 0
hearts of various stages of embryogenesis demonstrated a represented replicating chick embryonic myoblasts grown in the
dramatic increase of SRF mass between HH stage 11 and presence of 30 mM BudR for 60 hr. Myoblasts begin to fuse approxi-
Day 18 chick embryos during heart morphogenesis and mately 36 hr following BudR withdrawal. Biochemically differenti-
ated myotubes are observed in the 84-hr cultures. RNA hybridiza-served to show the monospeci®c nature of the SRF antibody
tion probes used in this analysis are described under Materials andused in this study (Fig. 4G). India ink stainings of elec-
Methods.troblotted proteins in Fig. 4F showed approximate equal
loadings of proteins that were extracted from isolated
hearts. The results of these experiments demonstrated that
SRF gene expression was developmentally regulated and
largely con®ned to the cardiac and skeletal muscle cell lin- blasts withdrew from the cell cycle, aligned, and fused into
multinucleated myotubes. SRF mRNA levels continued toeages, consistent with the developmental speci®c expres-
sion of a-actin genes in the avian embryo. increase, reaching the highest levels in differentiated myo-
tubes (84 hr following BudR withdrawal). The upregulation
of SRF transcripts preceded the appearance of skeletal a-
SRF Expression Regulated during Primary Avian actin gene transcripts, which were ®rst detected in 60-hr
Myogenesis myotubes, and paralleled the expression of the skeletal a-
actin gene following fusion.We wanted to determine the temporal and spatial expres-
sion pattern of SRF gene activity during primary avian myo- Expression and intracellular localization of SRF protein
was analyzed by immunoblotting (Fig. 6A). and immuno-genesis in culture, since SRF was shown to be expressed
primarily in late stage embryonic muscle (Fig. 1) and in ¯uorescence staining (Figs. 6B±6D) of primary chick myo-
blast cultures using two polyclonal antibodies; one raisedearlier embryonic somites (Figs. 2H±2I and 4D±4E). Be-
cause dissociated chick primary myoblasts rapidly with- against the SRF C-terminal speci®c epitope (see Materials
and Methods) and the other raised against bacterially ex-draw from the cell cycle and fuse following plating, the
entry to the differentiated state was inhibited by allowing pressed human SRF (Manak and Prywes, 1993). To exclude
possible cross-reactivity of antibody reaction with other re-myoblasts to cycle over 72 hr in the presence of BudR;
(Schwartz and Rothblum, 1981). Replicating myoblasts lated MADS box factors, a monospeci®c SRF antibody was
produced against a 15-amino-acid polypeptide epitope foundwere then released from the BudR differentiation block and
allowed to progress through myoblast fusion and terminal only in the carboxyl region of SRF corresponding to amino
acid numbers 405±418 in the human SRF sequence. Thisdifferentiation. Muscle-speci®c MyoD transcripts appeared
earliest and maximally within 12 hr following BudR with- region was absolutely conserved in avian, Xenopus, and hu-
man SRF. Whole cell protein extracts, collected from pri-drawal and then gradually declined during fusion, between
36 and 60 hr later (Fig. 5). SRF mRNA transcripts were not mary myoblast cultures at developmental timepoints, were
probed with the af®nity-puri®ed SRF antibody. Similar toevident in BudR replicating myoblasts. SRF message was
®rst detected 36 hr following BudR withdrawal, when myo- the induction of SRF mRNA, SRF protein levels, barely de-
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ated myotubes were estimated to be 40-fold higher than the
levels detected in replicating myoblasts. Immuno¯uores-
cence staining of myogenic cultures showed low levels of
nonnuclear SRF ¯uorescence, consistent with the downreg-
ulation of SRF gene activity in replicating BudR-treated
myoblasts (Fig. 6B). During myoblast fusion, SRF staining
was enhanced in the cytoplasm and along the elongated
®lopodia which connect the fusing myoblasts (Fig. 6C). SRF
immunostaining became localized to nuclei of fusing, post-
replicative myoblasts and differentiated myotubes (Figs. 6C
and 6D), correlating well with the rapid increase in a-actin
transcription. These results indicated that SRF expression
was upregulated during the withdrawal from the cell cycle
and the transport of SRF to myotube nuclei might be part
of a myogenic-regulated mechanism that precedes the ex-
pression of skeletal a-actin.
SRF Dominant-Negative Mutant Forms Dimers, but
Does Not Bind DNA
We evaluated the potency of an SRF dominant-negative
mutant to block endogenous SRF DNA-binding activity to
determine if the skeletal a-actin promoter was a direct tar-
get for SRF activity. The SRFpm1 mutant has three point
mutations in the DNA binding domain of SRF in which a
cluster of amino acids at positions Arg143, Lys145, and Leu146
of the human SRF that make critical base contacts were
converted to the neutral amino acids isoleucine, alanine,
and glycine respectively (Fig. 7A). These mutations leave
the SRF dimerization domain intact. Thus, SRFpm1 would
still foster SRF dimerization between mutant and wildtype
SRF monomers, while the binding of the heterodimer to its
DNA-binding target would be compromised (Kim et al.,
1994). Mobility shift binding studies were performed using
strategy of denaturation and co-renaturation of the polypep-
tides to evaluate this dominant negative mutant. As shown
in Fig. 6B, bacterially expressed SRFpm1 mutant was inca-
pable of binding to an SRE containing oligonucleotide du-
plex, whereas the full-length SRF1-508 (B1; band by homodi-
mer of wild-type SRF) and a C-terminal domain truncated
SRF1-244 (B3; band by homodimer of SRF1-244 ), which both
contain intact MADS box sequences, bound the SRE. ToFIG. 6. Appearance and accumulation of SRF protein during late
test the dominant negative activity of SRFpm1 in vitro, astage primary myogenesis. (A) Western analysis of SRF protein lev-
els during myogenesis. Cells were grown as in Fig. 4 and whole constant amount of SRF1-244 protein was mixed with serial
cell protein extracts were collected at selected time points. SRF molar excess of either wild type SRF (SRF1-508) or SRFpm1.
protein levels were detected by a monospeci®c SRF antibody made SRF1-508 and SRF1-244 protein formed functional heterodimers
against the 15-amino-acid epitope located in the carboxyl terminus (B2), which effectively bound to an SRE probe. The DNA-
of SRF. (B±D) Immuno¯uorescence of primary myoblasts grown binding activity of this heterodimer (B2) was as effective
on coverslips during BudR replication (B), midfusion (C), and postfu-
as wild-type SRF homodimer (B1). In contrast, addition ofsion myotubes (D). SRF localization was detected with the same
SRFpm-1 mutant with SRF1-244 formed nonfunctional heter-antibody utilized in Fig. 3 (Manak and Prywes, 1990).
odimers (B2) which lost most of its DNA-binding activity
(16 to
1
9 activity of wild-type SRF). SRFpm1 homodimers
showed no detectable DNA-binding activity (B1).
To determine if the SRFpm1 mutant was capable oftected in replicating myoblasts, increased approximately
10-fold during myoblast fusion, 48 hr after BudR with- inhibiting endogenous SRF DNA binding activity in pri-
mary myoblasts, SRFpm1, wild-type SRF, and the pCGNdrawal. The highest levels of SRF in terminally differenti-
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FIG. 7. A dominant-negative SRF mutant, SRFpm1, inhibited SRE-dependent DNA-binding activity. (A) Diagram of SRF expression
vectors show coding sequences of wild-type SRF [SRF(1±508aa)] and mutants fused to the hemagglutinin antigen epitope driven by the
CMV promoter. pSRFpm1 contained three point mutations in amino acid residues 143 (arginine to isoleucine), 145 (lysine to alanine),
and 146 (leucine to glycine). (B) SRFpm1 mutant dimerized with SRF, but did not bind DNA. Crude extracts from E. coli BL21 transformed
with various SRF expression plasmids, [SRF(1±508aa), SRFpm1, SRF(1±244aa)] were mixed as described under Materials and Methods and
were analyzed by gel-mobility shift assay using the SRE1 of the skeletal a-actin promoter as a probe. Homodimers of SRF(1±508aa), (B1),
heterodimers between SRF(1±244aa) and SRF(1±508aa) or SRFpm1 (B2), and homodimers of SRF(1±244aa) (B3) gave distinct EMSA shifts.
Note the reduction of binding activity of heterodimers (B2) when SRFpm1 was mixed with SRF(1±244aa). This binding activity was in
sharp contrast to the binding activity detected when SRF(1±508aa) was mixed with SRF(1±244). (C) Western blot expression of SRF
constructs in transient transfected myoblast cultures. The vector control (pCGN), wild-type SRF (pSRF), and the SRF dominant-negative
mutant (SRFpm1) were transfected into primary myoblast cultures. Whole cell extracts were collected (Lee et al., 1992) and probed with
the anti-HA antibody which recognized the ¯u epitope. (D) Expression of the SRFpm1 mutant reduced endogenous SRF DNA-binding
activity. Extracts collected in (C) were subjected to band shift analysis using the SRE1 of the skeletal a-actin promoter as a probe. All
extracts were collected 72 hr following transfection, from myotubes. Various amounts of whole cell protein extracts were added to the
shift reactions. Lanes 1, 5, and 9 contained 0 mg protein extract. Lanes 2, 6, and 10 contained 1.0 mg protein extract. Lanes 3, 7, and 11
contained 2.5 mg protein extract. Lanes 4, 8, and 12 contained 5.0 mg protein extract.
plasmid vector were transiently transfected into primary sis showed the SRFpm1 mutant was able to reduce the
DNA-binding activity of endogenous SRF (Fig. 7D). Cellschick myoblast cultures. Expression of the SRF con-
structs was driven by the constitutive CMV promoter. transiently transfected with SRFpm1 showed about a 50%
reduction of SRF binding compared to cells transfectedThis vector also encoded the HA ¯u epitope at the amino
terminus to allow detection of expression of the with the pCGN vector and about a 75% reduction in SRF
binding compared to cells transfected with wild-type SRFtransfected proteins. Whole cell extracts were collected
72 hr after transfection. Blots probed with the anti-HA (pSRF), as determined by Betagen scanning. Since these
constructs were transiently transfected into primaryepitope antiserum showed the transfected myotubes ex-
pressed the wild-type SRF and SRFpm1 constructs (Fig. myoblast cultures, full inhibition of SRF DNA-binding
activity was not detected. Nevertheless, these results in-7C). These extracts were then used for band shift analysis
to determine if the SRFpm1 mutant can affect DNA bind- dicated that the SRFpm1 dominant-negative mutant,
when transfected into primary myoblast cultures, showeding of endogenous cellular SRF. Using the SRE1 from the
skeletal a-actin promoter as a probe, DNA-binding analy- a signi®cant reduction in endogenous SRF DNA-binding
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activity, thus serving as a useful tool to study the func-
tional activity of SRF during myogenesis.
SRF pmI Blocked SRE-Dependent Skeletal a-Actin
Promoter Activity during Myogenesis
The speci®city of the SRFpm1 mutant was evaluated in
vivo, by cotransfection experiments with a variety of differ-
ent cis-regulatory elements linked to luciferase reporter
genes in primary chicken myoblasts (Fig. 8A). BudR-treated
replicating myoblasts were cotransfected with reporter gene
constructs and wild-type SRF, pCGN, or SRFpm1 expres-
sion vectors. Extracts were collected 72 hr following BudR
withdrawal and assayed for luciferase activity. We observed
that SRFpm1 inhibited the activity of the skeletal a-actin
promoter and a minimal SRE promoter (skSRE1), but did
not effect synthetic promoters containing multiple E boxes
or MCAT (TEF-1)-binding sites. The SRFpm1 mutant did
not display inhibitory activity on a promoter containing a
pair of MEF-2-binding sites (data not shown). These results
suggested that the SRFpm1 inhibitory activity was limited
to SRE cis-elements and that a single SRE cis-element was
suf®cient for SRFpm1 inhibitory activity. Evidently, this
mutant did not discriminate between SREs from either
muscle a-actin (skSRE1) or c-fos promoter (data not shown)
and exerted its inhibitory activity on intact SREs. We did
not observe a signi®cant induction in skeletal a-actin lucif-
FIG. 8. The SRFpm1 mutant blocked the activity of SRE con-erase activity with cotransfected pSRF probably due to a
taining promoters and the upregulation of the skeletal a-actin pro-
saturating effect seen with the overexpression of wild-type moter during myogenesis. All promoters were linked to a minimal
SRF (Lee et al., 1992). promoter containing the luciferase gene. Promoter activity was de-
To determine the role of SRF in skeletal a-actin gene termined and shown as histograms of relative luciferase activity.
expression, SRF mutants in DNA plasmid expression vec- Cotransfection of SRFpm1 only inhibited activity in the SRE con-
tors were transfected into cycling BudR treated myoblasts. taining promoters, skeletal a-actin promoter, and skeletal a-actin
SRE1 (skSRE1). SRFpm1 did not affect the activity of E box orThe SRFpm1 mutant was used to block the endogenous SRF
TEF-1 (M-CAT) containing promoters. Results were compared withDNA-binding activity by forming heterodimers with any
cotransfection of the control vector, pCGN, and wild-type SRF. (B)available wild-type SRF. A second mutant which lacked
SRFpm1 repressed skeletal a-actin promoter activity during myo-the SRF transactivation domain (pSRF 1-338) was evaluated
genesis. One hundred nanograms of SRF expression plasmid (wild-since it might compete with the wild-type SRF for DNA
type or mutant) or pCGN1 (control) was cotransfected with 500 ng
binding and act as a de facto repressor. Under these BudR of skeletal a-actin promoter fused to a luciferase reporter at 48 hr
conditions, mutant SRF proteins were allowed to accumu- after plating primary chicken myoblast with 30 mM BudR. Lucifer-
late, while the endogenous SRF gene remained silent. Myo- ase activity was measured at different time points following a
genesis was then initiated by BudR withdrawal in the pres- switch to differentiation media without BudR. Skeletal a-actin pro-
ence of excess mutant factors. Myoblasts cotransfected with moter activity was tested in the presence of SRFpm1 (square),
pSRF1-338 (circle), wild-type SRF (diamond), and pCGN vector (tri-the human SRF expression vector stimulated skeletal a-
angle). The plot of relative promoter activity of skeletal a-actinactin promoter activity 2- to 3-fold over control levels
was compared during the differentiation of chicken primary myo-through the early stages of BudR withdrawal, consistent
blast cells. Cells transfected with SRFpm1 showed repression ofwith the proposed role of SRF being a positive regulator of
skeletal a-actin expression even 80 hr following BudR withdrawal.the skeletal a-actin promoter (Lee et al., 1991). In compari-
Wild-type SRF and pCGN vector transfections showed the induc-
son, cotransfected SRFpm1 repressed the expression of skel- tion of skeletal a-actin promoter activity during myogenesis. Rela-
etal a-actin promoter throughout myogenesis to remain at tive luciferase activity values were normalized with CMV-bGAL.
background levels observed for replicating myoblasts under Values are means { the SE of three experiments.
BudR inhibition. The other SRF mutant (SRF1-338) provided
about a 75% reduction in a-actin promoter activity. As
shown in Fig. 7B, skeletal a-actin promoter activity was
induced over 50-fold throughout terminal differentiation as In order to determine if SRFpm1 speci®cally inhibited
SRF activity during myogenesis, wild-type SRF (pSRF) wasmeasured by luciferase activity in cells transfected with the
same amount of pCGN vector or wild-type SRF. cotransfected with the SRFpm1 mutant and tested for the
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neuronal tissues and virtually undetectable levels of SRF in
liver tissue of late stage avian embryos (Fig. 1). In addition,
we observed highly expressed levels of SRF mRNA in pre-
cardiac splanchnic mesoderm and dorsal somitic mesoderm
(Figs. 2±3). SRF protein was also shown to be selectively
expressed in the myocardium during heart morphogenesis
and in the myotomal segment of the anterior somites in
avian embryos (Fig. 4). Mohun et al. (1991) also found an
accumulation of Xenopus embryonic SRF transcripts fol-
lowing gastrulation, but the distribution of SRF protein in
embryonic tissues was not examined. Thus, high levels of
SRF expression appears to coincide with the transition of
going through gastrulation and neurulation when the ex-
pression of cardiac, skeletal, and smooth muscle a-actins
appear as early markers for terminal striated and smooth
FIG. 9. SRF expression rescued SRFpm1 blocked skeletal a-actin muscle differentiation (Ruzicka and Schwartz, 1988).
promoter activity. One hundred nanograms of SRFpm1 and 500 The variation in the developmental expression pattern
ng of skeletal a-actin promoter reporter constructs were added to between SRF mRNA and protein suggests that SRF expres-
primary myoblasts in the presence of 30 mM BudR. pSRF, MEF2, sion may be translationally regulated during avian develop-
and MyoD expression vectors were added at 25, 50, or 100 ng to ment. While SRF mRNA was detected at high levels
test for the ability to rescue the SRFpm1 repression of skeletal a- throughout the neural tube, myocardium, and somites, SRF
actin promoter activity. In the graph, the ®rst bar (0 ng) indicated
protein was detected predominantly in the myocardium andthat only 100 ng of SRFpm1 was added to the primary myoblasts
somites suggestive of a translationally regulated gene. Anal-and served as a baseline for rescue. Skeletal a-actin activity was
ysis of the human SRF gene revealed that SRF contains aabout four- to ®vefold higher in transfections containing pSRF and
relatively long GC rich 5* UTR and a long 3* UTR con-SRFpm1 than by SRFpm1 alone. Luciferase activity was normalized
by the amount of cell extract added to each luciferase assay. Values taining two polyadenylation signals. Earlier investigations
are means { the SE of three experiments. showed that SRF mRNA containing the 5* UTR was inef®-
ciently translated in reticulocyte lysate system (Norman et
al., 1988). A number of other genes, such as TGF-b, c-myc,
and nanos, have also been shown to be translationally regu-
ability of SRF to rescue the SRFpm1-inhibited skeletal a- lated by long 5* UTR's (Arrick et al., 1991; Parkin et al.,
actin promoter activity. BudR-treated myoblasts were co- 1985) or 3* UTRs (Wharton and Struhl, 1991). MEF2A has
transfected with SRFpm1 and increasing doses of pSRF, also been shown to be translationally regulated when vascu-
MEF-2, or MyoD expression vector plasmid DNA. A lucifer- lar smooth muscle cells were stimulated with mitogens
ase gene driven by the skeletal a-actin promoter was used (Suzuki et al., 1995). Perhaps like MEF2A which also con-
as a reporter construct. Myoblasts were collected and as- tains long 5* and 3* UTRs, SRF may also contain sequences
sayed for luciferase activity 36 hr following BudR with- required for translational control.
drawal. As shown in Fig. 9, myoblasts cotransfected with Expression of SRF in the early heart and skeletal muscle
pSRF and SRFpm1 displayed 4- to 5-fold restoration of skele- of the developing chick embryo suggests that SRF may be
tal a-actin promoter activity compared to myoblasts a critical factor required for proper heart and skeletal muscle
transfected with SRFpm1 alone. Cotransfections of MEF-2 formation. Early expression of SRF in the developing myo-
or MyoD with SRFpm1 did not signi®cantly recover skeletal cardium is similar to the expression of Nkx-2.5/Csx in the
a-actin promoter activity, which suggested that SRFpm1 mouse. Nkx-2.5 is a cardiac-speci®c homeobox gene related
displayed a rather exclusive SRF inhibitory activity. These to the Drosophila tinman gene, required for the elaboration
results strongly support the role of SRF as a myogenic-regu- of early mesoderm and heart primordia (Azpiazu and Frasch,
lated and restricted transcription factor, required for the 1993; Bodmer 1993). Nkx-2.5 is expressed in the myocardio-
expression of skeletal a-actin, a speci®c marker of terminal genic progenitor cells and the myocardium in the mouse
myogenic differentiation. and chicken (Komuro and Izumo, 1993; Lints et al., 1993;
Schultheiss et al., 1995). Recent studies from our laboratory
indicate that Nkx-2.5 physical association with SRF can
DISCUSSION drive the expression of the cardiac a-actin promoter in non-
myogenic ®broblasts (Chen et al., 1996). The recent homo-
zygous knockout of Nkx-2.5, which caused embryonic le-We observed differential SRF gene expression during
avian embryogenesis. Assays of SRF mRNA, protein, and thality, probably elicited by the failure to fold the heart tube
into a chambered heart and by the lack of myocardial cellDNA-binding activity indicated enrichment of SRF gene
products in striated and smooth muscle tissues. By these expansion associated with ventricular trabeculation (Lyons
et al., 1995), was suggestive of having an important role incriteria, lower but signi®cant SRF levels were detected in
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cardiogenesis. The coexpression of SRF and Nkx-2.5 and ment of SRF in some nonmyogenic cell types was below
detection in our assays, we cannot eliminate the possibilityperhaps other related Nkx homeodomain members ex-
pressed in cardiac progenitor cells may therefore be respon- at this time, that growth factor-induced SRF complexes
with Phox 1 and Elk-1 would be insuf®cient to mediatesible for the early expression of cardiac a-actin in the em-
bryo. serum-inducible events. For example, SRF-binding activity
was shown to be approximately two orders of magnitudeThe expression of SRF mRNA in the avian embryo is
similar to the expression pattern of the related MADS box greater in cardiac myocytes than in HeLa cells, the primary
cell system used to study SRF-dependent growth factor re-containing MEF-2 genes. Like SRF, MEF-2 is preferentially
expressed in human heart and skeletal muscle tissue (Yu et sponse (MacLellan et al., 1994). Thus, even trace amounts
of SRF appear to be suf®cient to mediate serum inducibilityal., 1992). During mouse embryogenesis, MEF-2C is acti-
vated early in the anterior lateral plate mesoderm prior to in most cell types. However, our observations clearly sup-
port a tissue-restricted expression pattern of SRF gene activ-the expression of muscle-speci®c structural genes. MEF-2A,
C, and D are detected in the myocardium and in the so- ity during early and late avian embryogenesis.
The recent elucidation of the X-ray crystal structure ofmites, suggesting an important role for SRF and MEF-2 in
developmental myogenic differentiation (Edumundson et the SRF core bound to DNA provides an explanation for the
inhibitory activity of the SRF mutant, SRFpm1 (Pellegrinial., 1994). The Drosophila homolog of MEF-2, d-mef2, is
expressed throughout the somatic and visceral mesoderm et al., 1995). A novel DNA-binding motif, a coiled-coil
formed by the MADS box a1 helices (aa153±aa179), liesfollowing gastrulation, and in the heart. d-mef2 mutant em-
bryos show a dramatic absence of differentiated somatic, parallel and on top of a narrow DNA minor groove making
contacts with the phosphate backbone on an SRE half site,cardiac, and visceral muscle ®bers (Lily et al., 1995; Bour
et al., 1995). The recent demonstration that MEF2 and myo- while within an unstructured N-terminal extension from
the aI helix (aa132±152aa) the Arg143 made critical basegenic basic helix-loop-helix proteins associate on DNA
raises the possibility that these two classes of myogenic contacts in the minor groove. Therefore, mutating the
Arg143 residue to a neutral amino acid weakened the criticaltranscription factors collaborate to induce muscle-speci®c
transcription of MEF-2-dependent genes (Molkentin et al., base contacts required for DNA binding, but did not partici-
pate in the dimerization of SRF monomers, which occurs1995). Therefore, a common property of these related MADS
box proteins could be their ability to cooperate with other above the aI helix by a structure composed of two b-sheets
in the monomer that interact with the same unit in itstranscriptional regulators to control gene expression of
downstream target genes. partner. We investigated the role of an SRF mutant,
SRFpm1, as a speci®c reagent to test the role of SRF inConcordant with its role as a positive regulator of a-actin
genes, we detected a signi®cant increase in SRF transcripts directing skeletal a-actin promoter activity. Analogous to
naturally occurring dominant-negative mutants, such as Idand protein mass during primary myogenesis in culture cor-
relating with the induction of skeletal a-actin (Figs. 5 and (Benezra et al., 1990), that form inactive heterodimers with
monomeric bHLH factors, we showed in Fig. 7 that SRFpm16) and cardiac a-actin (data not shown). SRF expression was
repressed in replicating myoblasts, while SRF mRNA and inhibited DNA binding to a great extent, while still
allowing for effective dimerization with wild-type SRF, thusprotein accumulated during the progression from primary
myoblast cultures to postdifferentiated myotubes. SRF ex- resulting in heterodimers incapable of ef®cient DNA bind-
ing. SRFpm1 displayed signi®cant dominant-negative activ-pression increased to its highest levels in postreplicative
myotubes, being localized to the nucleus, which preceded ity by inhibiting SRE containing promoter activity without
direct DNA binding, thus demonstrating a real requirementthe induction of skeletal a-actin expression during myo-
genic differentiation. Our results contrast those of Van- for the transfactor. In contradistinction, C-terminal activa-
tion domain SRF deletion mutants inhibited downstreamdromme et al. (1992) in which no signi®cant changes in
SRF levels were detected in the rat L6 and mouse C2C12 targets such as skeletal a-actin promoters (Fig. 7B) by direct
DNA binding to any available SRE, thus acting as a de factomyogenic cell lines during myogenesis in culture. This dis-
crepancy may be due to inherent differences between pri- repressor. We observed interference with endogenous SRF-
binding activity following ef®cient transfection assays ofmary cell cultures and highly passaged established cell
lines. For example, C2C12 cell were shown to poorly express replicating primary myoblasts with SRFpm1 (Fig. 7D). SRF
does not associate with other MADS box family membersskeletal a-actin gene activity in comparison to levels mea-
sured in primary myoblast cultures (Bains et al., 1984; Blau such as MEF-2/RSRF (Pollack and Treisman, 1991); accord-
ingly, we did not observe SRFpm1 inhibitory activity on aet al., 1985), and passaged C2C12 cell lines were incapable
of expressing a full complement of myogenic bHLH factors minimal MEF-2 promoter (data not shown).
Dominant-negative SRF activity might also be comple-that are found during embryonic primary myogenesis in
culture. Our observations that SRF gene activity displayed mented by the formation of nonfunctional SRF heterodim-
ers or SRFpm1 homodimers that could compete with endog-selective enrichment in embryonic myocardial-, skeletal-,
and smooth muscle-derived cell types should dispel any enous SRF for the binding of relevant accessory factors or
might even provide nonfunctional targets for phosphoryla-notion that SRF is a general factor with a limited range of
expression (Norman et al., 1988). Although the measure- tion events. Coexpression of SRFpm1 with reporter gene
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constructs maximally repressed the activity of the skeletal activator or repressor of transcription depending upon the
identity of an associated factor, such as the interaction be-a-actin promoter throughout myogenesis, supporting the
role of SRF as a differentiation factor in muscle cells. The tween MCM1 and MAT a2 (Keleher et al., 1989), another
homeodomain factor, which is critical for the establishmentinhibitory activity by SRFpm1 was shown to be rescued
only by the addition of SRF, indicating that SRFpm1 spe- of cell identity (the a and a-speci®c genes) in yeast. Hypo-
thetically, the increased levels of SRF in nonreplicatingci®cally inhibited SRF activity (Fig. 9). Similarly, we re-
cently observed that stable transfections of Sol 8 and C2C12 skeletal myoblasts and cardiac myocytes might repress the
nonmyogenic c-fos promoter through forming nonproduc-myogenic cell lines with SRFpm1 inhibited myoblast fusion
and postreplicative myogenic differentiation. SRFpm1- tive complexes through its SRE that compete off serum
growth factor induced SRF/Elk-1/Phox1 complexestransfected cells were unable to express myogenin and
blocked skeletal a-actin gene activity, as in the ®ndings (Grueneberg et al., 1994). Therefore, large changes in SRF
cellular content might be part of a mechanism that medi-of Vandromme et al. (1992) in which microinjected SRF
antibodies blocked C2C12 myogenic differentiation. In ad- ates accessory factor interactions that may either activate
or repress transcription of various target genes. As demon-dition, expression of genes involved in cellular proliferation
did not appear to be affected by the SRF mutant (data not strated by modest co-transactivation of the skeletal a-actin
promoter as shown in Fig. 8, and by Lee et al. (1992) in-shown). These results further support the notion that SRF
has an integral role during myogenic differentiation. creased SRF levels alone are not totally suf®cient for driving
the a-actin gene activity. Therefore, we predict that theAlthough it is generally assumed that SRF serves a role
as a constitutive factor during its association with accessory appearance of a myogenic coaccessory protein factor(s)
might play an important role in the muscle-speci®c expres-factors, we have shown that SRF-binding activity actually
increased dramatically following the ending of the cell repli- sion of skeletal a-actin that will associate with the in-
creased nuclear content of SRF during myogenesis.cation primarily due to change in the cellular content of
SRF in primary myoblasts (Lee and Schwartz, 1992). We
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